Interventions for previously untreated patients with AIDS-associated Non-Hodgkin´s Lymphoma-Reference-Cited by-同舟云学术

Interventions for previously untreated patients with AIDS-associated Non-Hodgkin´s Lymphoma

Published:2009-07-08 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Martí-Carvajal Arturo J¹,Cardona Andrés Felipe²,Lawrence Able³

Affiliation:

1. Iberoamerican Cochrane Network; Valencia Edo. Carabobo Venezuela 2001

2. Catalan Institute of Oncology, Hospital Germans Trias I Pujol; Department of Medical Oncology; Carretera de Canyet s/n Badalona Barcelona Spain 08916

3. Sanjay Gandhi Postgraduate Institute of Medical Sciences; Department of Immunology; SGPGIMS, Raebareli Road Lucknow Uttar Pradesh India 226014

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD005419.pub2/fullpdf

Reference117 articles.

1. Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010;Kaplan;Blood,2005

2. Kaplan LD Scadden DT Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010 Proceedings of the American Society of Clinical Oncology 2003 564

3. Kaplan L Kahn J Crowe S Volberding P Grossberg H McManus N Mills J International Conference on AIDS A randomized trial of chemotherapy with or without recombinant granulocyte monocyte colony stimulating factor (rGMCSF) in HIV-associated non-Hodgkin's lymphoma (NHL): effect of treatment on serum HIV p24 antigen levels International Conference on AIDS 1990 213 ( Abstract S.B.510)

4. Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial;Kaplan;Journal of Clinical Oncology,1991

5. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection;Kaplan;New England Journal of Medicine,1997

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients;Blood;2013-11-07

2. Follow-up of patients receiving rituximab for diffuse large B cell lymphoma: an overview of systematic reviews;Annals of Hematology;2013-06-10

3. Pharmaceutical follow-up for patients on rituximab therapy for non-Hodgkin lymphoma: what is the evidence?;International Journal of Clinical Pharmacy;2013-06-05

4. Lymphoma in Other Diseases;Neoplastic Diseases of the Blood;2012-07-27

5. Rituximab in combination with chemotherapy versus chemotherapy alone in HIV-associated non-Hodgkin lymphoma: A pooled analysis of 15 prospective studies;American Journal of Hematology;2012-02-03